募投项目实施

Search documents
新锐股份: 新锐股份第五届董事会第十七次会议决议公告
Zheng Quan Zhi Xing· 2025-08-27 12:13
证券代码:688257 证券简称:新锐股份 公告编号:2025-039 苏州新锐合金工具股份有限公司 第五届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、会议召开和出席情况 苏州新锐合金工具股份有限公司(以下简称"公司")第五届董事会第十 七次会议于2025年8月26日以现场和通讯相结合的方式召开。会议由董事长吴何 洪先生主持,本次董事会会议应出席董事7人,实际出席董事7人,公司全体监 事、高管列席了会议。会议的召开符合《中华人民共和国公司法》(以下简称 "《公司法》")及《公司章程》有关规定,所作决议合法有效。 二、议案审议情况 (一)审议通过《关于公司2025年半年度报告及其摘要的议案》 公司2025年半年度报告的编制和审核程序符合相关法律法规及《公司章 程》、公司内部管理制度的各项规定。公司2025年半年度报告公允地反映了公 司2025年半年度的财务状况和经营成果等,所披露的信息真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏。 本议案已经审计委员会审议通过。 表决结果:7票 ...
均普智能: 国泰海通证券股份有限公司关于宁波均普智能制造股份有限公司部分募投项目增加实施主体及开立募集资金专户的核查意见
Zheng Quan Zhi Xing· 2025-08-22 13:12
国泰海通证券股份有限公司 关于宁波均普智能制造股份有限公司 部分募投项目增加实施主体及开立募集资金专户 一、募集资金基本情况 中国证券监督管理委员会于 2022 年 1 月 18 日核发《关于同意宁波均普智能 制造股份有限公司首次公开发行股票注册的批复》(证监许可[2022]125 号), 公司获准以首次公开发行方式向社会公众发行人民币普通股(A 股)30,707.07 万 股,发行价格 5.08 元/股,募集资金总额为人民币 1,559,919,156.00 元,扣除各项 发行费用后的实际募集资金净额为人民币 1,418,966,238.97 元。天健会计师事务 所(特殊普通合伙)对公司本次首次公开发行股票的资金到位情况进行了审验, 并于 2022 年 3 月 17 日出具了《验资报告》(天健验[2022]6-9 号)。 为规范公司募集资金管理和使用,保护投资者权益,公司设立了募集资金专 项账户。募集资金到账后,已全部存放于经公司董事会批准开设的募集资金专项 账户内,公司已与保荐机构和存放募集资金的商业银行签订募集资金专户存储三 方监管协议。 二、募集资金使用情况 截至 2025 年 6 月 30 日,公司 ...
科兴制药: 中信建投证券股份有限公司关于科兴生物制药股份有限公司使用部分募集资金向全资子公司提供无息借款以实施募投项目的核查意见
Zheng Quan Zhi Xing· 2025-08-15 16:24
Summary of Key Points Core Viewpoint - The company plans to use part of the raised funds to provide interest-free loans to its wholly-owned subsidiary for the implementation of fundraising projects, which has been reviewed and approved by the sponsor institution [1][9]. Fundraising Overview - The company raised a total of RMB 1,109.25 million through its initial public offering, with a net amount of RMB 994.64 million after deducting issuance costs [1]. - The total planned investment for the fundraising projects is RMB 1,771.79 million, with the company intending to allocate RMB 994.64 million from the raised funds [2]. Use of Funds - The company previously provided an interest-free loan of RMB 50 million to its subsidiary Shenzhen Kexing Pharmaceutical for the "R&D Center Upgrade Project" [2][3]. - The current plan includes an additional interest-free loan of RMB 20 million to the same subsidiary for ongoing R&D projects, bringing the total loan amount to RMB 120 million [4][5]. Project Progress - As of June 30, 2025, the cumulative investment in the R&D Center Upgrade Project is RMB 347.46 million, with RMB 290.63 million already utilized, resulting in a shortfall of RMB 56.83 million [4]. - The remaining balance in the dedicated fundraising account for this project is RMB 73.96 million, which includes net income from financial products and bank interest [4]. Financial Data of the Subsidiary - As of December 31, 2024, the subsidiary reported total assets of RMB 535.61 million, net assets of RMB 278.31 million, operating income of RMB 316.77 million, and net profit of RMB 51.75 million [7]. Approval Process - The use of funds for the interest-free loan has been approved by the company's board and supervisory board, complying with relevant regulations [9].
晶华微(688130.SH):向晶华智芯提供不超过3500万元的借款以实施募投项目“研发中心建设项目”
Ge Long Hui A P P· 2025-07-29 13:04
Group 1 - The company, Jinghua Micro (688130.SH), announced the convening of its second board meeting on July 29, 2025, to review and approve the proposal for using part of the raised funds to provide loans to its wholly-owned subsidiary, Shenzhen Jinghua Zhixin Microelectronics Co., Ltd. [1] - The approved loan amount is up to 35 million yuan, aimed at implementing the fundraising project for the "Research and Development Center Construction Project" [1]
平安电工: 中信证券股份有限公司关于湖北平安电工科技股份公司新增全资子公司作为部分募投项目的实施主体及新开设募集资金专户的核查意见
Zheng Quan Zhi Xing· 2025-07-23 16:23
Core Viewpoint - The company has added a wholly-owned subsidiary as an implementation entity for part of its fundraising projects and opened a new fundraising account, which is aimed at improving the efficiency of fund usage and ensuring the progress of the investment project [1][4]. Fundraising Basic Situation - The company issued 46.38 million shares at a price of RMB 17.39 per share, raising a total of RMB 806.55 million. After deducting issuance costs of RMB 79.00 million, the net amount raised is RMB 727.55 million [1][2]. New Implementation Entity for Fundraising Projects - The original implementation entity for the "Wuhan Production Base Construction Project" was the wholly-owned subsidiary, Hubei Ping An Electric Industry Co., Ltd. The company has added Hubei Taikai Aneng Technology Co., Ltd. as a new implementation entity, maintaining the original fundraising amount of RMB 122.92 million for the project [2][3]. Basic Situation of New Implementation Entity - The new implementation entity is involved in various manufacturing and sales activities, including mica products, electrical equipment, and hardware products [3]. Fundraising Management After Adding New Entity - The company will open a special fundraising account for the new implementation entity and sign a four-party supervision agreement to monitor the storage and usage of the raised funds [3][4]. Purpose and Impact of Adding New Implementation Entity - The addition of the new implementation entity is based on the actual needs of the company's business development, which is expected to enhance the efficiency of fund usage and ensure the timely progress of the investment project [4][5]. Review and Approval Procedures - Both the board of directors and the supervisory board have approved the addition of the new subsidiary and the opening of the fundraising account, confirming that the decision aligns with the company's needs and does not harm shareholder interests [4][5]. Sponsor's Verification Opinion - The sponsor has verified that the addition of the new subsidiary and the opening of the fundraising account have been approved by the necessary corporate governance bodies and comply with relevant regulations [5].
杰瑞股份: 国信证券关于杰瑞股份使用自筹资金支付募投项目所需资金并以募集资金等额置换事项的核查意见
Zheng Quan Zhi Xing· 2025-07-10 16:22
Summary of Key Points Core Viewpoint - The company intends to use self-raised funds to pay for investment project expenses and subsequently replace these with raised funds, ensuring efficient use of capital and smooth project implementation [1][7][8]. Group 1: Fundraising and Allocation - The company successfully raised a total of RMB 2,499,999,974.82 through a non-public issuance of 69,098,949 shares at RMB 36.18 per share, with a net amount of RMB 2,487,483,821.84 after deducting issuance costs [1]. - As of November 30, 2023, the remaining balance for the original investment project was RMB 758.205 million, which will be redirected to a new oil and gas technology service project [2]. Group 2: Project Management and Adjustments - The company held a temporary shareholders' meeting on January 18, 2024, to approve the change of use for the remaining funds from the original project to the new project [2]. - The company has extended the deadline for the digital transformation phase one project and the oil and gas technology service project to December 31, 2027, without changing the investment amounts [3]. Group 3: Use of Self-raised Funds - The company plans to use self-raised funds for initial payments on investment projects, which will later be replaced by raised funds to enhance efficiency [4][5]. - The rationale for using self-raised funds includes compliance with banking regulations, operational efficiency, and cost reduction in procurement [4][5]. Group 4: Operational Procedures - A detailed operational process has been established for using self-raised funds, including contract signing, payment applications, and monthly reporting to the sponsor institution [6]. - The financial department will maintain a special ledger to track the replacement of self-raised funds with raised funds, ensuring transparency and accountability [6]. Group 5: Approval and Oversight - The board of directors and the supervisory board have approved the use of self-raised funds, confirming that the process adheres to legal and regulatory requirements [7]. - The sponsor institution has conducted a review and found no issues with the company's plan to use self-raised funds, ensuring that shareholder interests are protected [7][8].